Oncology & Cancer

FDA experts debate timing of pap test

(HealthDay)—The Pap test has been a routine gynecological procedure for generations of American women. But on Wednesday, a Food and Drug Administration advisory panel is considering whether to delay the Pap test and use ...

Oncology & Cancer

Technology can help patients facing routine decisions

(HealthDay)—Information technology can be harnessed to assist patients facing routine decisions, according to a study published in the May/June issue of the Annals of Family Medicine.

Obstetrics & gynaecology

FDA warns about genetic noninvasive prenatal screening tests

Noninvasive prenatal screening (NIPS) tests may yield false results or inappropriate interpretations of results, according to a safety communication issued by the U.S. Food and Drug Administration.

page 40 from 40